AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
0.6340
+0.0631 (11.05%)
At close: Feb 6, 2026
AccuStem Sciences Market Cap
AccuStem Sciences has a market cap or net worth of $10.19 million as of February 9, 2026. Its market cap has increased by 135.03% in one year.
Market Cap
10.19M
Enterprise Value
10.22M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.63
Market Cap Chart
Since March 2, 2022, AccuStem Sciences's market cap has decreased from 20.42M to 10.19M, a decrease of -50.10%. That is a compound annual growth rate of -16.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 10.19M | -22.07% |
| Dec 31, 2025 | 13.07M | 157.22% |
| Dec 31, 2024 | 5.08M | -28.40% |
| Dec 29, 2023 | 7.10M | -53.62% |
| Dec 30, 2022 | 15.31M | -25.04% |
| Mar 2, 2022 | 20.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zeo ScientifiX | 15.23M |
| Inhibitor Therapeutics | 13.77M |
| HOOKIPA Pharma | 13.50M |
| TRON Group | 11.43M |
| LakeShore Biopharma | 10.72M |
| Biomind Labs | 8.84M |
| Zenith Capital | 7.99M |
| Curative Biotechnology | 7.94M |